BMEA
Biomea Fusion, Inc.
$0.60
+2.58% Oct 23 close
BMEASPY
1W
-30.9%
1M
-58.3%
3M
-52.0%
6M
-68.2%
YTD
-51.6%
1Y
-56.5%
Live chart
Loading live chart…
What they do
Healthcare · Biotechnology
For information only · Important disclosures
Grades vs sector
No sector grades for BMEA yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.
Systematic Models
Not held by any of our 5 live models right now.
Quality Growth
Outside this model's universe or screens
Momentum Top 15Outside this model's universe or screens
Momentum BlendNot in the current book
New Highs GrowthOutside this model's universe or screens
Coteau Long BookNot in the current book
News
More newsTop Premarket Decliners
MT Newswires · Oct 14
Biomea Fusion’s BMF-650 Shows Up to 6.1% Weight Loss in Early GLP-1 Study
MarketBeat · Oct 13
Biomea Fusion Announces Phase 1 Results for BMF-650, its Investigational Next-Generation Oral Small Molecule GLP-1 Receptor Agonist
GlobeNewswire · Oct 13
Biomea Fusion to Announce Phase I Results for BMF-650, Its Next-Generation Oral Small-Molecule GLP-1 Receptor Agonist
GlobeNewswire · Oct 12
Sector Update: Healthcare Stocks Decline Late Afternoon
MT Newswires · Sep 23
Key stats
Market value$53.2M
P/E (next 12 months, estimated)-0.8
52-week range$0.74 – $2.24
Dividend yieldNo dividend
Analyst consensusBuy (6)
Average analyst price target$6.17 (+928%)
Valuation and fundamentals
Valuation & fundamentals
Loading the valuation from SEC filings…
Earnings
Next report · quarter Sep 2026
Tue Nov 3, 2026Time not confirmed
EPS consensus-$0.22 range -$0.28–-$0.17
Revenue consensus$0 7 analysts
Last 4 quarters · EPS vs estimate
Aug 5, 2026-$0.17est -$0.23+25.6%Above estimates
May 11, 2026-$0.17est -$0.19+10.3%Above estimates
Mar 24, 2026-$0.12est -$0.22+45.6%Above estimates
Nov 4, 2025-$0.24est -$0.29+17.6%Above estimates
In line = within 1% of the estimate.
EstimateActual (beat)Actual (miss)
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $0 | – |
| 2026-03-31 | $0 | – |
| 2025-12-31 | $0 | – |
| 2025-09-30 | $0 | – |
| 2025-06-30 | $0 | – |
Rating changes
Reiterated
2026-10-14 · Citizens reiterated Market Outperform on BMEA
Reiterated
2026-10-14 · HC Wainwright & Co. reiterated Buy on BMEA
Initiated
2026-10-07 · Brookline Capital started covering BMEA at Buy
Initiated
2026-05-05 · Citizens started covering BMEA at Market Outperform
Reiterated
2026-04-28 · D. Boral Capital reiterated Buy on BMEA
Reiterated
2026-04-08 · D. Boral Capital reiterated Buy on BMEA
Third-party analyst actions, not Coteau's views. All rating changes
Stats refreshed 2026-10-21 01:29:51 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Free to use. No card, no ads, no auto-renew.
Independent research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app
Beta 0.9 · Oct 21, 2026